NYSE Arca · HTEC

ROBO Global Healthcare Technology and Innovation ETF (HTEC)

$44.07−2.37%
Close Nov 12, 2026 · split-adjusted
Nov 12, 2026$44.07▲ 29.20% in range
Nov 12, 2025Low $31.85 · High $47.09Nov 12, 2026
What changed · written from our data
As of Nov 12, 2026

ROBO Global Healthcare Technology and Innovation ETF closed at $44.07 on Nov 12, down 2.37%, 6.4% below its 52-week closing high. Volume of 547.9K shares was 9.19× its 20-day average (well above normal).

Split-adjusted performance: +2.8% over one month, +31.9% over six months, +29.9% over one year.

Short interest was 12.9K shares at the Oct 30 settlement, up 381.4% from the prior report (1.0 days to cover).

Market cap$109.1M2.5M shares
Revenue · quarter——
Diluted EPS——
P/E · TTM—
Net margin—
Dividend yield0.79%$0.3463 last paid
52-week range31.85 – 47.09−6.4% from high
Volume547.9K9.19× 20-day avg
Volatility · 60d25.2%Annualised
Short % of float—1.0 days to cover
Net cash—
Next earnings—Not scheduled
Split-adjusted performance
1W −2.0%1M +2.8%3M +7.9%6M +31.9%YTD +24.8%1Y +29.9%3Y +87.1%5Y −8.3%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Short interest

Details →
Shares short12.9K+381.4% vs prior
Days to cover1.0Settled Oct 30
% of float—
Short vol. 10d29.8%of daily volume

News about ROBO Global Healthcare Technology and Innovation ETF

All news →

No recent articles focused on ROBO Global Healthcare Technology and Innovation ETF.

Quick answers

What is HTEC's market cap?
$109.07M, based on the Nov 12 close of $44.07.
Does ROBO Global Healthcare Technology and Innovation ETF pay a dividend?
Yes. The latest regular dividend was $0.3463 per share (ex-date Dec 30), an annualised yield of 0.79%.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology